GLP-1 receptor agonists move from weight loss into the longevity conversationGLP-1 receptor agonists move from weight loss into the longevity conversation
GLP-1 receptor agonists move from weight loss into the longevity conversation GLP-1 receptor agonists are quickly shifting from niche metabolic drugs to something much broader in clinical conversation. What started as a treatment for type 2 diabetes is now firmly embedded in obesity care and increasingly discussed in the context of long term health and Read More
People Who Stopped Taking Ozempic Are Sharing What Actually Happened — And The Answers Are Surprisingly HonestPeople Who Stopped Taking Ozempic Are Sharing What Actually Happened — And The Answers Are Surprisingly Honest
“That Costco hot dog hit the spot.” View Entire Post › “That Costco hot dog hit the spot.” View Entire Post ›
Weight-loss drugs tied to lower death, recurrence risk after breast cancerWeight-loss drugs tied to lower death, recurrence risk after breast cancer
New research published in JAMA Network Open suggests that there is a positive association between GLP-1 agonists—drugs commonly used to treat obesity and diabetes—and better outcomes among breast cancer patients.
“I Just Can’t Afford To Go Through That Again”: People Are Getting Brutally Honest About What They Wish They Knew Before Taking GLP-1s, And It’s Eye-Opening”I Just Can’t Afford To Go Through That Again”: People Are Getting Brutally Honest About What They Wish They Knew Before Taking GLP-1s, And It’s Eye-Opening
“I wish that my mother could have taken GLP-1s. Her entire world would have changed, and she would probably still be alive today. Remember, skeptics, obesity can be deadly.” View Entire Post › “I wish that my mother could have taken GLP-1s. Her entire world would have changed, and she would probably still be Read More
Breast cancer that has begun to spread could be controlled for longer with targeted radiotherapyBreast cancer that has begun to spread could be controlled for longer with targeted radiotherapy
Treating breast cancer that has begun to spread around the body with targeted radiotherapy could help patients to live longer without their cancer getting worse, according to the results of a small randomized controlled trial presented at the Congress of the European Society for Radiotherapy and Oncology (ESTRO 2026).
New obesity guidance urges dietitian-led care as GLP-1 drugs reshape treatmentNew obesity guidance urges dietitian-led care as GLP-1 drugs reshape treatment
Obesity and dietitian societies have joined forces to issue a new consensus statement on recommendations surrounding the use of obesity drugs for weight loss treatment. The consensus statement was presented at the European Congress on Obesity (ECO 2026) in Istanbul, Turkey, and co-authored by lead author Dr. Laurence Dobbie, Department of Population Health Sciences, School Read More
GLP-1 Drug Makes Its Case for Treating Plaque PsoriasisGLP-1 Drug Makes Its Case for Treating Plaque Psoriasis
(MedPage Today) — Adding a dual GLP-1/GIP receptor agonist to the psoriasis drug ixekizumab (Taltz) significantly improved outcomes in adults with difficult-to-treat plaque psoriasis due to overweight or obesity, the open-label TOGETHER-PsO trial… (MedPage Today) — Adding a dual GLP-1/GIP receptor agonist to the psoriasis drug ixekizumab (Taltz) significantly improved outcomes in adults with Read More
Jackie Tohn Opens up About Her Health Scare With Breast CancerJackie Tohn Opens up About Her Health Scare With Breast Cancer
Jackie Tohn opens up to TODAY’s Jenna Bush Hager and Sheinelle Jones about her recent health scare where she learned she has an 85 percent chance of developing breast cancer and her decision to undergo a double mastectomy. She also discusses the third season of “Nobody Wants This” and facing off against Macaulay Culkin on “Celebrity Jeopardy.”
Wegovy initiation may cut migraine drug use 8% in women after one yearWegovy initiation may cut migraine drug use 8% in women after one year
A nationwide study from Denmark presented at the European Congress on Obesity (ECO2026) in Istanbul, Turkey, shows that use of semaglutide (Wegovy) for weight management is associated with a 7% reduction in the use of triptan-class drugs for treatment of migraine one year after initiation. A nationwide study from Denmark presented at the European Congress Read More
Why breast cancer becomes more deadly with ageWhy breast cancer becomes more deadly with age
Researchers at Georgetown’s Lombardi Comprehensive Cancer Center have identified a mechanism that may help explain a key reason why older people experience worse outcomes from breast cancer. The study implicates RAGE (Receptor for Advanced Glycation End-products), a cell surface receptor that amplifies inflammatory signaling, and which also becomes increasingly active with metastatic progression.